Dr. Kapur is a scientist, engineer and entrepreneur with 20 years of experience in developing and commercializing nascent technologies from premier academic laboratories. He has co-founded and built successful innovative companies in partnership with leading academics from Massachusetts General Hospital, MIT and Carnegie Mellon. He co-founded the non-invasive prenatal screening company Verinata Health (acquired by Illumina), and shaped the drug discovery platform at Cellomics (acquired by ThermoFisher). He co-directs the Innovation Ecosystem at the MGH for development of Microfluidic Platform Technologies for Clinical Medicine. He earned his master’s degree and doctorate in Bioengineering at Clemson University, with an undergraduate degree in Electrical Engineering from India. Dr. Kapur has 23 issued and 50 pending US and International patents.
Dr. Ronald Tompkins is the Sumner Redstone Professor of Surgery at the Harvard Medical School and the Chief of the Division of Surgery, Science & Bioengineering at Massachusetts General Hospital. Dr. Tompkins is widely recognized for his work in translational science and engineering. He received a B.S. degree in Chemistry from Tulane University, an M.D. degree from Tulane Medical School, and a ScD degree in medical and chemical engineering from the Massachusetts Institute of Technology. Ron has an outstanding track record in high-impact publications, outstanding trainee outcomes, and productive research translation and commercialization. As PI of the NIGMS program, “Inflammation and the Host Response to Injury” – the largest award ever received by Partners Healthcare and 10th largest funded extramural NIH grant – Ron has contributed new paradigms in the understanding of human systems biology and also leads advances in microarrays, high throughput databases for human proteomics, novel cell separation technologies, and advanced bioinformatics methods and algorithms. He has served on dozens of boards and committees and published more than 460 research contributions in medicine and engineering journals toward the advancement of science and engineering. He has delivered over 1,000 invited keynote and scientific meeting presentations and received numerous honors and awards. Dr. Tompkins provides clinical leadership for the Company’s product lines.
Dr. Toner is the Helen Andrus Benedict Professor of Bioengineering at the Massachusetts General Hospital, Harvard Medical School, and Harvard-MIT Health Sciences & Technology. He is internationally recognized for his research at the interface of nanotechnology, microsystems engineering, microfluidics and applications in clinical medicine. Dr. Toner was born in Istanbul, Turkey. He obtained his undergraduate degree in mechanical engineering at the Istanbul Technical University, and his master’s degree and doctorate in Medical Engineering at Harvard-MIT. He is the author of more than 350 original scientific and technical publications, and an inventor on more than 50 patents. He is a fellow of the National Academy of Inventors.